neratinib maleate

A drug used to treat adults with breast cancer that is HER2 positive. It is used with capecitabine in adults whose disease is advanced or has spread to other parts of the body and has already been treated with at least two other anti-HER2 therapies. It is also used as extended adjuvant treatment in adults with early-stage disease that has already been treated with adjuvant trastuzumab. It is also being studied in the treatment of other types of cancer. Neratinib maleate blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called Nerlynx.